Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20453888rdf:typepubmed:Citationlld:pubmed
pubmed-article:20453888lifeskim:mentionsumls-concept:C0006142lld:lifeskim
pubmed-article:20453888lifeskim:mentionsumls-concept:C0111429lld:lifeskim
pubmed-article:20453888lifeskim:mentionsumls-concept:C1704675lld:lifeskim
pubmed-article:20453888lifeskim:mentionsumls-concept:C1704824lld:lifeskim
pubmed-article:20453888lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:20453888lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:20453888pubmed:issue27lld:pubmed
pubmed-article:20453888pubmed:dateCreated2010-7-8lld:pubmed
pubmed-article:20453888pubmed:abstractTextHER2/neu (HER2) and cyclin E are important prognostic indicators in breast cancer. As both are involved in cell cycle regulation we analyzed whether there was a direct interaction between the two. HER2 and cyclin E expression levels were determined in 395 breast cancer patients. Patients with HER2-overexpression and high levels of cyclin E had decreased 5-year disease-specific survival compared with low levels of cyclin E (14% versus 89%, P<0.0001). In vitro studies were performed in which HER2-mediated activity in HER2-overexpressing breast cancer cell lines was downregulated by transfection with HER2 small interfering RNA or treatment with trastuzumab. Cyclin E expression levels were determined by western blot analysis, and functional effects analyzed using kinase assays, MTT assays were used to assess cell viability as a marker of proliferation and fluorescence-activated cell sorting analysis was used to determine cell cycle profiles. Decreased HER2-mediated signaling resulted in decreased expression of cyclin E, particularly the low molecular weight (LMW) isoforms. Decreased HER2 and LMW cyclin E expression had functional consequences, including decreased cyclin E-associated kinase activity and decreased proliferation, because of increased apoptosis and an increased accumulation of cells in the G1 phase. In vivo studies performed in a HER2-overexpressing breast cancer xenograft model confirmed the effects of trastuzumab on cyclin E expression. Given the relationship between HER2 and cyclin E, in vitro clonogenic assays were performed to assess combination therapy targeting both proteins. Isobologram analysis showed a synergistic interaction between the two agents (trastuzumab targeting HER2 and roscovitine targeting cyclin E). Taken together, these studies show that HER2-mediated signaling effects LMW cyclin E expression, which in turn deregulates the cell cycle. LMW cyclin E has prognostic and predictive roles in HER2-overexpressing breast cancer, warranting further study of its potential as a therapeutic target.lld:pubmed
pubmed-article:20453888pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:languageenglld:pubmed
pubmed-article:20453888pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:citationSubsetIMlld:pubmed
pubmed-article:20453888pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20453888pubmed:statusMEDLINElld:pubmed
pubmed-article:20453888pubmed:monthJullld:pubmed
pubmed-article:20453888pubmed:issn1476-5594lld:pubmed
pubmed-article:20453888pubmed:authorpubmed-author:LieIIlld:pubmed
pubmed-article:20453888pubmed:authorpubmed-author:HuntK KKKlld:pubmed
pubmed-article:20453888pubmed:authorpubmed-author:TuckerS LSLlld:pubmed
pubmed-article:20453888pubmed:authorpubmed-author:McKenzieTTlld:pubmed
pubmed-article:20453888pubmed:authorpubmed-author:BiernackaAAlld:pubmed
pubmed-article:20453888pubmed:authorpubmed-author:MeijerLLlld:pubmed
pubmed-article:20453888pubmed:authorpubmed-author:KeyomarsiKKlld:pubmed
pubmed-article:20453888pubmed:authorpubmed-author:ShawM VMVlld:pubmed
pubmed-article:20453888pubmed:authorpubmed-author:AkliSSlld:pubmed
pubmed-article:20453888pubmed:authorpubmed-author:MittendorfE...lld:pubmed
pubmed-article:20453888pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20453888pubmed:day8lld:pubmed
pubmed-article:20453888pubmed:volume29lld:pubmed
pubmed-article:20453888pubmed:ownerNLMlld:pubmed
pubmed-article:20453888pubmed:authorsCompleteYlld:pubmed
pubmed-article:20453888pubmed:pagination3896-907lld:pubmed
pubmed-article:20453888pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:20453888pubmed:meshHeadingpubmed-meshheading:20453888...lld:pubmed
pubmed-article:20453888pubmed:meshHeadingpubmed-meshheading:20453888...lld:pubmed
pubmed-article:20453888pubmed:meshHeadingpubmed-meshheading:20453888...lld:pubmed
pubmed-article:20453888pubmed:meshHeadingpubmed-meshheading:20453888...lld:pubmed
pubmed-article:20453888pubmed:meshHeadingpubmed-meshheading:20453888...lld:pubmed
pubmed-article:20453888pubmed:meshHeadingpubmed-meshheading:20453888...lld:pubmed
pubmed-article:20453888pubmed:meshHeadingpubmed-meshheading:20453888...lld:pubmed
pubmed-article:20453888pubmed:meshHeadingpubmed-meshheading:20453888...lld:pubmed
pubmed-article:20453888pubmed:meshHeadingpubmed-meshheading:20453888...lld:pubmed
pubmed-article:20453888pubmed:meshHeadingpubmed-meshheading:20453888...lld:pubmed
pubmed-article:20453888pubmed:meshHeadingpubmed-meshheading:20453888...lld:pubmed
pubmed-article:20453888pubmed:meshHeadingpubmed-meshheading:20453888...lld:pubmed
pubmed-article:20453888pubmed:meshHeadingpubmed-meshheading:20453888...lld:pubmed
pubmed-article:20453888pubmed:meshHeadingpubmed-meshheading:20453888...lld:pubmed
pubmed-article:20453888pubmed:meshHeadingpubmed-meshheading:20453888...lld:pubmed
pubmed-article:20453888pubmed:meshHeadingpubmed-meshheading:20453888...lld:pubmed
pubmed-article:20453888pubmed:meshHeadingpubmed-meshheading:20453888...lld:pubmed
pubmed-article:20453888pubmed:meshHeadingpubmed-meshheading:20453888...lld:pubmed
pubmed-article:20453888pubmed:meshHeadingpubmed-meshheading:20453888...lld:pubmed
More...